Canada markets closed

Hanmi Science Co., Ltd. (008930.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
33,550.00-350.00 (-1.03%)
At close: 03:30PM KST

Hanmi Science Co., Ltd.

14 Wiryeseong-daero
Songpa-gu
Seoul 05545
South Korea
82 2 410 9114
https://www.hanmiscience.co.kr

Sector(s)Healthcare
IndustryMedical Distribution
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Sung-Ki LimFounder & ChairmanN/AN/A1940
Mr. Lim Chong-YoonChief Executive Officer, President and DirectorN/AN/A1972
Mr. Jong-Soo Woo Ph.D.President & DirectorN/AN/A1967
Mr. Se-Chang GwonPresident & DirectorN/AN/A1963
Mr. Chan Seob KimCFO & Senior MDN/AN/A1965
Mr. Jong-Ho LimManaging Director of Administration, Purchasing & ManagementN/AN/A1961
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.

Description

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.

Corporate Governance

Hanmi Science Co., Ltd.’s ISS Governance QualityScore as of May 1, 2024 is 8. The pillar scores are Audit: 1; Board: 8; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.